Example: Heart Attack

Clinical Trials on Borderline Resectable Adenocarcinoma of the Head of the Pancrease

Total 9779 results

NCT01993004

Completed

Immune Regulation in Multiple Sclerosis: The Effect of Glatiramer Acetate on MicroRNA Expression in Antigen-Presenting Cells

Multiple Sclerosis
NCT02711566

Completed

Robot-based Rehabilitation of Upper Limb Impairment in Multiple Sclerosis (MS-ROBOT)

Multiple Sclerosis
NCT00811902

Completed

Efficacy, Safety, and Tolerability of Nerispirdine in Patients With Multiple Sclerosis

Multiple Sclerosis
NCT01632293

Completed

Evaluating Intervention Responsiveness in People With Multiple Sclerosis

Multiple Sclerosis
NCT00483652

Completed

Study of Fampridine-SR Tablets in Multiple Sclerosis Patients

Multiple Sclerosis
NCT01512329

Completed

Pacing Activity Self-management for Patients With Multiple Sclerosis

Multiple Sclerosis
NCT02485223

Unknown

Single Test to ARrive at MS Diagnosis. Using a Single MRI Brain Scan to Help Diagnose Multiple Sclerosis (STAR-MS)

Multiple Sclerosis
NCT00430599

Completed

The Effect of Levetiracetam (Keppra) on the Treatment of Tremor in Multiple Sclerosis

Multiple Sclerosis
NCT02314585

Unknown

Fall Risk Reduction in Multiple Sclerosis (FIRMS) (FIRMS)

Multiple Sclerosis
NCT01795872

Completed

Follow-up Study After 11 Years of Patients Who Were Included in the BENEFIT Trial (304747) With a First Demyelinating Event Suggestive of Multiple Sclerosis

Multiple Sclerosis
NCT00477113

Completed

TYSABRI Global Observational Program in Safety (TYGRIS)

Multiple Sclerosis
NCT01874340

Terminated

Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple Sclerosis

Multiple Sclerosis
NCT01299025

Completed

Balance Training for People With Multiple Sclerosis Using Nintendo Wii Fit

Multiple Sclerosis
NCT01081275

Unknown

Improving Hand Use in Multiple Sclerosis

Multiple Sclerosis
NCT01582126

Completed

Group Balance Training for People With Multiple Sclerosis

Multiple Sclerosis
NCT00852722

Completed

Low Fat Diet and Multiple Sclerosis (MS)

Multiple Sclerosis
NCT01302431

Completed

Nurse-Led Manualized Telephone Support Intervention

Multiple Sclerosis
NCT01419301

Completed

Mindfulness Based Stress Reduction in Multiple Sclerosis (MS)

Multiple Sclerosis
NCT01112657

Completed

An Observational Study on the Progression of Clinically Isolated Syndrome to Multiple Sclerosis Over a 2-year Period (NEO)

Multiple Sclerosis
NCT01101776

Completed

Post Marketing Surveillance Study to Evaluate the Tolerability of Rebif® New Formulation in Patients With Relapsing Multiple Sclerosis in an Australian Clinical Setting. (ReNew)

Multiple Sclerosis
NCT01080573

Completed

Rebif Compliance Support Program - Assessing Needs in Multiple Sclerosis (AIMS)

Multiple Sclerosis
NCT00516893

Completed

Natalizumab High Titer Immunogenicity and Safety

Multiple Sclerosis
NCT02131285

Completed

Stabilometric Assessment of Balance Recovery in Persons With Multiple Sclerosis

Multiple Sclerosis
NCT01624714

Unknown

Study of Alemtuzumab in Treatment Refractory MS Subjects/Alemtuzumab Naive & Alemtuzumab Experienced Subjects

Multiple Sclerosis
NCT01074346

Completed

Tolerability of Rebif® (Interferon-beta 1-A) Therapy in Korean Patients With Multiple Sclerosis

Multiple Sclerosis
NCT01195870

Completed

Assessment of Patient Use of a New Device: RebiSmart

Multiple Sclerosis
NCT01228266

Terminated

Mesenchymal Stem Cell Transplantation in MS (CMM-EM)

Multiple Sclerosis
NCT01195857

Completed

Assessment of Subject Use of the Rebiject II Injection Device According to Nurse Examination of Subject Accuracy in 10 Steps as a Dummy Demonstration

Multiple Sclerosis
NCT01435694

Completed

Robot-assisted Gait Training in Multiple Sclerosis Subjects

Multiple Sclerosis
NCT01918501

Unknown

Testing Mitochondria Activity and Blood Lipid Content of Multiple Sclerosis Patients

Multiple Sclerosis
NCT01679041

Terminated

High Dose Chemo With Stem Cell Transplant as Treatment for Multiple Sclerosis That Failed Prior Treatment

Multiple Sclerosis
NCT01587690

Completed

Immune Regulation in Multiple Sclerosis: MicroRNA and Antigen-Presenting Cells

Multiple Sclerosis
NCT00735007

Completed

12-week Study to Evaluate RebiSmart™ Suitability for Self Injection in Relapsing Multiple Sclerosis.

Multiple Sclerosis
NCT01535664

Completed

An Open Label, Proof of Concept Study to Evaluate the Effects of Dalfampridine Withdrawal on Gait and Balance Parameters in Subjects With Multiple Sclerosis (MS)

Multiple Sclerosis
NCT00142402

Completed

Modafinil in Multiple Sclerosis

Multiple Sclerosis
NCT00765544

Terminated

Targeted Lower Extremity Joint Training

Multiple Sclerosis
NCT01181115

Completed

Avonex Safety and Tolerability in Chinese Subjects With Relapsing Multiple Sclerosis (MS) (Avonex China)

Multiple Sclerosis
NCT01404117

Withdrawn

A Multinational, Randomized, Double-blind, Parallel-group, Placebo-controlled Study Assessing the Safety and Tolerability

Relapsing Multiple Sclerosis
NCT01036165

Completed

A Multicenter, Open-label, RebiSmart™ Autoinjector Ease of Use Study (Performs)

Multiple Sclerosis
NCT00958009

Completed

The Multicenter, Open-label, Single-use Autoinjector Convenience Study

Multiple Sclerosis
NCT00836719

Completed

Safety of Polyphenon E in Multiple Sclerosis Pilot Study

Multiple Sclerosis
NCT00166283

Completed

Improving New Learning and Memory in Multiple Sclerosis

Multiple Sclerosis
NCT01768039

Unknown

Vitamine D in Multiple Sclerosis (MSVit)

Multiple Sclerosis
NCT01753375

Unknown

Role of Vitamin D in Reducing the Relapse Rate in Patients With Multiple Sclerosis

Multiple Sclerosis
NCT00618527

Completed

Combination Therapy Using Cellcept and Rebif in RRMS

Multiple Sclerosis
NCT01279655

Terminated

Motor Training and White Matter in Multiple Sclerosis (MS)

Multiple Sclerosis
NCT00630383

Withdrawn

Immunoregulation by Controlled Parasite Exposure in Multiple Sclerosis. (WIRMS-1)

Multiple Sclerosis
NCT00229502

Completed

Cognitive Effects of Immunomodulatory Drugs in MS

Multiple Sclerosis
NCT00544037

Completed

BENEFIT Extension Study

Multiple Sclerosis
NCT00648908

Completed

Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR Tablets in Multiple Sclerosis Patients Who Participated in the MS-F203 Trial

Multiple Sclerosis

Clinical Trials on Borderline Resectable Adenocarcinoma of the Head of the Pancrease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations